Orthofix Medical Inc.
NASDAQ Global SelectRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Orthofix Medical Inc. (OFIX) develops, manufactures, and distributes medical devices and biologics focused on musculoskeletal healing. The company offers a comprehensive portfolio of products including spinal implant systems such as the M6-C and M6-L artificial cervical and lumbar discs, the Maestro and Ascentx systems for minimally invasive spine surgery; bone growth therapies like the Orthofix Bone Growth Therapy devices utilizing pulsed electromagnetic field technology; extremity fixation devices including the Fitbone intramedullary lengthening system and the TL-HEX circular external fixator; and regenerative biologics such as Osteocel cellular allografts and VersaShield synthetic bone void fillers. Orthofix serves orthopedic surgeons, neurosurgeons, and patients requiring treatment for spinal disorders, nonunion fractures, congenital deformities, and trauma through direct sales forces, independent distributors, and strategic partnerships. Founded in 1980 and headquartered in Lewisville, Texas, the company operates globally across North America, Europe, Asia-Pacific, and Latin America, with manufacturing facilities in the United States, Italy, and Mexico. In recent developments, Orthofix completed the acquisition of SeaSpine Holdings Corp in early 2023, significantly expanding its biologics and spinal implant offerings; launched the new Janusz posterior spinal correction system in late 2024; and entered a strategic distribution partnership with Zimmer Biomet for bone growth therapy devices in select international markets during 2025. [ from prior searches on company overview][ from recent changes search]
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical Inc. (NASDAQ: OFIX)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical Inc. (NASDAQ: OFIX)
Orthofix to Participate in Upcoming Investor Conferences
Orthofix to Participate in Upcoming Investor Conferences
Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting
Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights
Orthofix Medical Inc. (OFIX) Q1 2026 Earnings Call Transcript
Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance
Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc. - OFIX
Orthofix to Report First Quarter 2026 Financial Results
Orthofix Medical (NASDAQ:OFIX) Insider Jorge Andres Cedron Sells 3,743 Shares of Stock
Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc. - OFIX
Head-To-Head Survey: Vasamed (OTCMKTS:VSMD) vs. Orthofix Medical (NASDAQ:OFIX)
Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc. - OFIX
Orthofix Realigns Spine Leadership to Strengthen Focus and Execution
Orthofix Medical Inc. $OFIX Stake Lifted by JPMorgan Chase & Co.
Reviewing Orthofix Medical (NASDAQ:OFIX) and CVRx (NASDAQ:CVRX)
Down 12.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Orthofix (OFIX)
Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights
OFIX Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Orthofix Medical Inc. – OFIX